RenovoRx (RNXT) EBIT (QoQ) (2020 - 2026)
RenovoRx (RNXT) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - |
| 10 | RenovoRx | 60.54 Mn | 60.54 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.46% |
| Mar 31, 2026 | 1.50% |
| Dec 31, 2025 | -10.06% |
| Sep 30, 2025 | -19.49% |
| Jun 30, 2025 | 13.89% |
| Mar 31, 2025 | -18.16% |
| Dec 31, 2024 | 6.93% |
| Sep 30, 2024 | 6.79% |
| Jun 30, 2024 | -22.54% |
| Mar 31, 2024 | -39.34% |
| Dec 31, 2023 | 40.43% |
| Sep 30, 2023 | 11.61% |
| Jun 30, 2023 | -3.50% |
| Mar 31, 2023 | -50.28% |
| Dec 31, 2022 | -0.42% |
| Sep 30, 2022 | 17.33% |
| Jun 30, 2022 | 13.01% |
| Mar 31, 2022 | -27.55% |
| Dec 31, 2021 | -68.89% |
| Sep 30, 2021 | -61.09% |